Navigation Links
FDA News & Notes - Week of May 16, 2011
Date:5/16/2011

SILVER SPRING, Md., May 16, 2011 /PRNewswire-USNewswire/ -- Science, public health, and regulatory highlights for this week from the U.S. Food and Drug Administration. Information in this document is designed for credentialed journalists. Release dates and times for items are current as of May 16, 2011.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

FDA News & Notes does not contain any regulatory or enforcement actions due to legal limitations.

Events and Speeches for the Commissioner and FDA leadership:

Tuesday, 5/17 – FDA Commissioner Margaret Hamburg, M.D., will speak on "Ensuring Global Food Safety through International Regulatory Cooperation" at the Asian Pacific Economic Cooperation's (APEC) Food Safety Cooperation Forum in Big Sky, Mont. A copy of the Commissioner's speech will be available upon request.

Press Office Contact: Doug Karas, 301-796-2805, douglas.karas@fda.hhs.gov

Wednesday, 5/18 – Commissioner Hamburg will provides remarks at a Memorandum of Understanding signing between the APEC and the World Bank, Food Safety Cooperation Forum. The two organizations will work collaboratively to improve the food safety capabilities of APEC member economies through training and the sharing of best practices and lessons learned. http://www.apec2011.gov/index.htm.  

Press Office Contact: Doug Karas, 301-796-2805, douglas.karas@fda.hhs.gov

Thursday, 5/19 – FDA Deputy Commissioner for Foods Mike Taylor will deliver a major policy address on the core principle of the new FDA Food Safety Modernization Act, prevention, and how it has been embraced by the public health community and the food industry as the key to effective food safety reform. 1 p.m., George Washington University, Jack Morton Auditorium, 805 21st Street, NW, Washington D.C.

Press Office Contact: Doug Karas, 301-796-2805, douglas.karas@fda.hhs.gov

Meetings, Workshops and Congressional Testimony:

Monday, 5/16 – The Pediatric Advisory Committee will discuss pediatric-focused safety reviews for a number of products as well as discuss Topical Calcineurin Inhibitors Elidel and Protopic. 8 a.m., Hilton Hotel, 8727 Colesville Road, Silver Spring, Md.

Press Office Contact: Jeff Ventura, 301-796-2807, jeffrey.ventura@fda.hhs.gov

Tuesday, 5/17 and Wednesday, 5/18 – Joint Meeting of Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee will review the safety and effectiveness of current over-the-counter acetaminophen dosing standards in children under 2 years of age and those between 2 and 12. 8 a.m., Hilton Hotel, 8727 Colesville Road, Silver Spring, Md.

Press Office Contact: Jeff Ventura, 301-796-2807, jeffrey.ventura@fda.hhs.gov

Tuesday, 5/17 – Learn about FDA's global inspection program during a 30-minute webinar. Question and answer segment following the presentation. 12:30 p.m. Webinar slides are posted online.

Thursday, 5/19 – Endocrinologic and Metabolic Drugs Advisory Committee will discuss the findings of the Action to Control Cardiovascular Risk in Diabetes-Lipid trial as they relate to the efficacy and safety of the approved new drug application for TRILIPIX (fenofibric acid) delayed release capsules. 8 a.m., Hilton Hotel, 8727 Colesville Road, Silver Spring, Md.
Press Office Contact: Morgan Liscinsky, 301-796-0397, morgan.liscinsky@fda.hhs.gov

Friday, 5/20 – Science Board Advisory Committee Meeting will discuss the report from the subcommittee's review of the Pharmacovigilance Program at the Center for Drug Evaluation and Research. The board will be provided with updates on FDA's nanotechnology research program plans and Comparative Effectiveness Research. Background materials should be available at least two business days before the meeting. 9 a.m., 10903 New Hampshire Ave., Bldg. 31, Room 1503, Silver Spring, Md.

Press Office Contact: Jeff Ventura, 301-796-2807, jeffrey.ventura@fda.hhs.gov

FDA Office of Public Affairs Contact Information:
Call or email FDA Office of Public Affairs, 301-796-4540, fdaopa@fda.hhs.gov

List of FDA press officers and beats

More Resources:
FDA News and Events

FDA Photos  (Flickr)

Consumer Health Information


'/>"/>
SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Caldolor® Clinical Study in Hospitalized Burn Patients Published in Journal of Burn Care & Research
2. Top Industry Professional Joins Aphena as Head of Quality & Regulatory Affairs
3. Kaiser Permanente Study Challenges Concerns on Effectiveness of Administering Pneumococcal & Shingles Vaccines Together
4. Joint HHC/GHX Project Earns Honors in Supply & Demand Chain Executives 2011 Executive 100
5. Intercell AG Announces Q1 2011 Results and Updates on R&D Progress
6. Wilson Sonsini Goodrich & Rosati Expands IP Litigation Practice
7. Lexicon Pharmaceuticals Announces Webcast of 2011 Annual R&D Day
8. American Regent Initiates Nationwide Voluntary Recall of Caffeine & Sodium Benzoate Injection, USP 250 mg/mL, 2 mL Single Dose Vial Due to Visible Particulates
9. ThermoGenesis Reports Third Quarter Fiscal 2011 Results; Major Progress Achieved in China & India
10. Pharmaceutical Litigation Partner James Stronski Joins Crowell & Moring
11. Reportlinker Adds European Market for Cardiac Rhythm Management, Electrophysiology & Ablation Devices 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... innovative inhaled drugs, announced today that it was added ... reconstituted its comprehensive set of U.S. and global ... is an important milestone for Pulmatrix," said Chief Executive ... awareness of our progress in developing drugs for crucial ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
Breaking Medicine News(10 mins):